Avelumab safe and yields durable responses for patients with advanced Merkel cell carcinoma
The immunotherapeutic avelumab (Bavencio) was well tolerated by patients with advanced Merkel cell carcinoma, and the majority of those whose cancer responded to avelumab treatment had durable responses, according to results ...
Apr 3, 2017
0
0